Skip to content
Screener

Ginkgo Bioworks DNA Other Revenue — Total

Similar metrics at other companies

Telos Corporation logo
TLSCost of sales – services — Total
$202K+35.6%
KKR & Co. logo
KKRInsurance — Total
$19.66M-15.9%
Rimini Street, Inc. logo
RMNIReportable Segment — Total
$2.66M-1.5%
KKR & Co. logo
KKRAsset Management — Total
$206.2M+37.2%
PAR Technology logo
PARReportable Segment — Total
$6.76M-14.3%
Quanterix Corporation logo
QTRXService and other revenue — Total stock-based compensation expense
$217K-9.6%

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$515.15M-26.8%
Enterprise value$747.25M-15.2%
P/S4.6×+1.3×

Profitability

See full
Gross margin91.8%—
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity1×+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The source filing: Ginkgo Bioworks’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 4:34 PM EST
Fiscal year
FY2025
Accession
0001628280-26-012346
Line itemYear Ended December 31, 2025Year Ended December 31, 2024Year Ended December 31, 2023
Research and development$34,210$56,020$145,879
General and administrative42,46356,32484,005
Cost of Biosecurity revenue2,624——
Cost of other revenue2,249——
Total$81,546$112,344$229,884

Item 16. Form 10-K Summary

FAQ

What is Ginkgo Bioworks's other revenue — total?
Ginkgo Bioworks (DNA) reported other revenue — total of $562.25K in Q4 2025.
What does other revenue — total mean?
This metric represents the total revenue generated from business activities that fall outside of the company's primary operating segments. It captures income streams that are ancillary to the core cell programming and biosecurity service offerings. Monitoring this figure helps investors identify emerging business lines or non-core revenue sources that may eventually scale into significant contributors.

Ask your AI about Ginkgo Bioworks's other revenue — total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude